Bryn Bumpas
Surgical · Dallas, TXNPI 1740851633
Payments from drug & device makers
What this record shows
This record is dominated by education: $4,800 of the $6,317 with a category attached, or 76.0%. 8 manufacturers reported payments, led by Arthrex at 50.3% of the total. Reporting peaked in 2022 at $4,625 and has fallen 95.1% since, to $228 in 2025. Among surgical clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 35 payments — averaging $180.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$3K
- Pylant Medical$3K
- Ferring Pharmaceuticals Inc.$249
- Johnson & Johnson$49
- Vertex$37
- Integra Lifesciences Corporation$27
- plus $39 from 2 others
What the payments were for
- Travel & lodging$64710%
- Food & beverage$87014%
- Education$4,80076%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 11 | $3,180 |
| Pylant Medical | 6 | $2,736 |
| Ferring Pharmaceuticals Inc. | 11 | $249 |
| Johnson & Johnson | 1 | $49 |
| Vertex | 2 | $37 |
| Integra Lifesciences Corporation | 2 | $27 |
| Cumberland Pharmaceuticals, Inc. | 1 | $20 |
| Avanos Medical | 1 | $19 |
How this compares
$6,317 in reported general payments places this provider in the 95th percentile of 804 surgical providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 65 | $188 |
| Celecoxib | 13 | $106 |
| Methylprednisolone | 19 | $104 |
Paid to pharmacies, not to this prescriber.
Other surgical in Dallas
- Josephine KarlDallas$18K
- Lonnie GinnDallas$17K
- Gretchen WilsonDallas$16K
- Jessica GreenemeierDallas$9K
- Kriste HaileDallas$8K
- Erin TenneyDallas$8K
- Brittany BuckmasterDallas$7K
- Kelly CampbellDallas$5K
- Dallin WoottonDallas$5K
- Alexandria SandersDallas$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.